News on Essential_Thrombocytosis from BioPortfolio.com http://www.BioPortfolio.com Consolidated Essential_Thrombocytosis news from BioPortfolio.com Tue, 09 Feb 2010 17:27:07 GMT en Hiru Corporation's (HIRU) Medicine Added to the 'National Essential Drug List'http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034104&HITNO=0&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034104&THISHREF=http://c.moreover.com/click/here.pl%3fz2535630464%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034104&HITNO=0&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034104&THISHREF=http://c.moreover.com/click/here.pl%3fz2535630464%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKSLA: Hiru Corporation's (HIRU) Medicine Added to the 'National Essential Drug List'http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032631&HITNO=1&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032631&THISHREF=http://c.moreover.com/click/here.pl%3fz2534742152%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032631&HITNO=1&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032631&THISHREF=http://c.moreover.com/click/here.pl%3fz2534742152%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTickerTech.com: Hiru Corporation's (HIRU) Medicine Added to the 'National Essential Drug List'http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032624&HITNO=2&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032624&THISHREF=http://c.moreover.com/click/here.pl%3fz2534740115%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032624&HITNO=2&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032624&THISHREF=http://c.moreover.com/click/here.pl%3fz2534740115%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Hiru Corporation's (HIRU) Medicine Added to the 'National Essential Drug List'http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032728&HITNO=3&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032728&THISHREF=http://c.moreover.com/click/here.pl%3fz2534782326%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032728&HITNO=3&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032728&THISHREF=http://c.moreover.com/click/here.pl%3fz2534782326%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKLFY: Xenaderm: An Essential Wound Care Therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034195&HITNO=4&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034195&THISHREF=http://c.moreover.com/click/here.pl%3fz2535675092%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034195&HITNO=4&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034195&THISHREF=http://c.moreover.com/click/here.pl%3fz2535675092%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Maintenance of Cell Culture Conditions Essential for Biomedical Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030531&HITNO=5&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030531&THISHREF=http://c.moreover.com/click/here.pl%3fz2533671994%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030531&HITNO=5&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030531&THISHREF=http://c.moreover.com/click/here.pl%3fz2533671994%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLab Medica: Maine could tell drug makers to discard old medshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027631&HITNO=6&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027631&THISHREF=http://c.moreover.com/click/here.pl%3fz2532264070%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027631&HITNO=6&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027631&THISHREF=http://c.moreover.com/click/here.pl%3fz2532264070%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWichita Eagle: First Fairtrade beauty products hit UK shelveshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023774&HITNO=7&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023774&THISHREF=http://c.moreover.com/click/here.pl%3fz2528395633%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023774&HITNO=7&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023774&THISHREF=http://c.moreover.com/click/here.pl%3fz2528395633%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCosmetics Design Europe: 3D-Echocardiographic Guidance of Septal Defect Closure Interventions: Desirable or Essential?http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023125&HITNO=8&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023125&THISHREF=http://c.moreover.com/click/here.pl%3fz2528036958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023125&HITNO=8&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023125&THISHREF=http://c.moreover.com/click/here.pl%3fz2528036958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTCTMD.com: Proposal to subsidise medical supplieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018825&HITNO=9&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018825&THISHREF=http://c.moreover.com/click/here.pl%3fz2525951026%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018825&HITNO=9&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018825&THISHREF=http://c.moreover.com/click/here.pl%3fz2525951026%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy News: Subsidies to cure patientsEUR rising costshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018458&HITNO=10&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018458&THISHREF=http://c.moreover.com/click/here.pl%3fz2525691164%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018458&HITNO=10&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018458&THISHREF=http://c.moreover.com/click/here.pl%3fz2525691164%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy News: Research and Markets: Ono Pharmaceutical Co., Ltd. - SWOT Analysis: The Essential Source For Top-Level Company Data Andhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013841&HITNO=11&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013841&THISHREF=http://c.moreover.com/click/here.pl%3fz2523843367%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013841&HITNO=11&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013841&THISHREF=http://c.moreover.com/click/here.pl%3fz2523843367%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Research and Markets: Cubist Pharmaceuticals, Inc. - SWOT Analysis: The Essential Source For Top-Level Company Data andhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014246&HITNO=12&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014246&THISHREF=http://c.moreover.com/click/here.pl%3fz2523939161%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014246&HITNO=12&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014246&THISHREF=http://c.moreover.com/click/here.pl%3fz2523939161%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Research and Markets: Cubist Pharmaceuticals, Inc. - SWOT Analysis: The Essential Source For Top-Level Companyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014139&HITNO=13&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014139&THISHREF=http://c.moreover.com/click/here.pl%3fz2523904277%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014139&HITNO=13&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014139&THISHREF=http://c.moreover.com/click/here.pl%3fz2523904277%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire UK: Research and Markets: Ono Pharmaceutical Co., Ltd. - SWOT Analysis: The Essential Source For Top-Level Companyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013898&HITNO=14&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013898&THISHREF=http://c.moreover.com/click/here.pl%3fz2523854293%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013898&HITNO=14&MSIZE=228&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Essential_Thrombocytosis&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013898&THISHREF=http://c.moreover.com/click/here.pl%3fz2523854293%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire UK: